US 10513703
Hepatitis B virus (HBV) iRNA compositions and methods of use thereof
granted A61KA61K31/713A61K45/06
Quick answer
US patent 10513703 (Hepatitis B virus (HBV) iRNA compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/713, A61K45/06, A61P, A61P1/16